Literature DB >> 3499813

Familial aggregation in noncirrhotic portal fibrosis: a report of four families.

S K Sarin1, N K Mehra, A Agarwal, V Malhotra, B S Anand, V Taneja.   

Abstract

Noncirrhotic portal fibrosis is a common cause of portal hypertension in India. We report four families with more than one member afflicted with this disorder. Six of the seven (85.5%) patients in whom HLA studies were carried out were HLA-DR 3 positive. The possibility of an immunogenetic basis of noncirrhotic portal fibrosis should be investigated further.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3499813

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  12 in total

Review 1.  Non-cirrhotic portal fibrosis.

Authors:  S K Sarin
Journal:  Gut       Date:  1989-03       Impact factor: 23.059

Review 2.  Clinical characteristics of idiopathic portal hypertension.

Authors:  Ozgur Harmanci; Yusuf Bayraktar
Journal:  World J Gastroenterol       Date:  2007-04-07       Impact factor: 5.742

Review 3.  Idiopathic Non-Cirrhotic Intrahepatic Portal Hypertension (NCIPH)-Newer Insights into Pathogenesis and Emerging Newer Treatment Options.

Authors:  Ashish Goel; Joshua E Elias; Chundamannil E Eapen; Banumathi Ramakrishna; Elwyn Elias
Journal:  J Clin Exp Hepatol       Date:  2014-07-28

Review 4.  The current clinical aspects of idiopathic portal hypertension.

Authors:  Tomohiro Tanaka; Yasuhiko Sugawara; Norihiro Kokudo
Journal:  Intractable Rare Dis Res       Date:  2013-08

Review 5.  Idiopathic portal hypertension and extrahepatic portal venous obstruction.

Authors:  Rajeev Khanna; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2018-02-20       Impact factor: 6.047

6.  Familial occurrence of nodular regenerative hyperplasia of the liver: a report on three families.

Authors:  J Dumortier; O Boillot; M Chevallier; F Berger; P Potier; P J Valette; P Paliard; J Y Scoazec
Journal:  Gut       Date:  1999-08       Impact factor: 23.059

7.  Analysis of inherited thrombophilic mutations and natural anticoagulant deficiency in patients with idiopathic portal hypertension.

Authors:  Kadim Bayan; Yekta Tüzün; Serif Yilmaz; Naime Canoruc; Mehmet Dursun
Journal:  J Thromb Thrombolysis       Date:  2008-08-07       Impact factor: 2.300

Review 8.  Idiopathic Non-Cirrhotic Portal Hypertension and Porto-Sinusoidal Vascular Disease: Review of Current Data.

Authors:  Michel Kmeid; Xiuli Liu; Samuel Ballentine; Hwajeong Lee
Journal:  Gastroenterology Res       Date:  2021-04-21

Review 9.  Idiopathic non-cirrhotic portal hypertension: a review.

Authors:  Jeoffrey N L Schouten; Joanne Verheij; Susana Seijo
Journal:  Orphanet J Rare Dis       Date:  2015-05-30       Impact factor: 4.123

10.  Bone morphogenetic protein receptor 2 in patients with idiopathic portal hypertension.

Authors:  Andrea De Gottardi; Susana Seijo; Montserrat Milá; M Isabel Alvarez; Miquel Bruguera; Juan G Abraldes; Jaime Bosch; Juan-Carlos García-Pagán
Journal:  J Cell Mol Med       Date:  2012-09       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.